These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35074971)

  • 21. Droplet digital polymerase chain reaction for detection and quantification of cell-free DNA TP53 target somatic mutations in oral cancer.
    Lin LH; Cheng HW; Liu CJ
    Cancer Biomark; 2022; 33(1):29-41. PubMed ID: 34366328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid.
    Cornelli L; Van Paemel R; Ferro Dos Santos MR; Roelandt S; Willems L; Vandersteene J; Baert E; Mus LM; Van Roy N; De Wilde B; De Preter K
    Clin Epigenetics; 2024 Jul; 16(1):87. PubMed ID: 38970137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
    Li B; Pu K; Ge L; Wu X
    Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating cell-free DNA variables as marker of ovarian cancer patients: A pilot study.
    Stamenkovic S; Cheng J; Surowy H; Burwinkel B; Gündert M
    Cancer Biomark; 2020; 28(2):159-167. PubMed ID: 32176629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients.
    Valpione S; Gremel G; Mundra P; Middlehurst P; Galvani E; Girotti MR; Lee RJ; Garner G; Dhomen N; Lorigan PC; Marais R
    Eur J Cancer; 2018 Jan; 88():1-9. PubMed ID: 29175734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
    Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
    Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
    [No Abstract]   [Full Text] [Related]  

  • 27. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
    Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
    Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.
    Park S; Lee EJ; Rim CH; Seong J
    Yonsei Med J; 2018 Jun; 59(4):470-479. PubMed ID: 29749129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
    Yu Z; Qin S; Wang H
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification.
    Liu L; Toung JM; Jassowicz AF; Vijayaraghavan R; Kang H; Zhang R; Kruglyak KM; Huang HJ; Hinoue T; Shen H; Salathia NS; Hong DS; Naing A; Subbiah V; Piha-Paul SA; Bibikova M; Granger G; Barnes B; Shen R; Gutekunst K; Fu S; Tsimberidou AM; Lu C; Eng C; Moulder SL; Kopetz ES; Amaria RN; Meric-Bernstam F; Laird PW; Fan JB; Janku F
    Ann Oncol; 2018 Jun; 29(6):1445-1453. PubMed ID: 29635542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observations.
    Nygård L; Ahlborn LB; Persson GF; Chandrananda D; Langer JW; Fischer BM; Langer SW; Gabrielaite M; Kjær A; Rosenfeld N; Mouliere F; Østrup O; Vogelius IR; Bentzen SM
    PLoS One; 2020; 15(4):e0231884. PubMed ID: 32343749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients.
    Mazurek AM; Rutkowski T; Fiszer-Kierzkowska A; Małusecka E; Składowski K
    Oral Oncol; 2016 Mar; 54():36-41. PubMed ID: 26786940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
    Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
    Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-free DNA as a biomarker for colorectal cancer: a retrospective analysis in patients before and after surgery.
    Zhong Y; Zhou Q; Zhang Y; Zhou S; Zhang G; Jiang C; Zhang Z; Zhang X; Xu J; Jin C; Cao L; Chen L
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):135-141. PubMed ID: 32415940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum cell-free DNA levels are a useful marker for extramammary Paget disease.
    Mijiddorj T; Kajihara I; Tasaki Y; Otsuka-Maeda S; Sakamoto R; Sawamura S; Kanazawa-Yamada S; Egashira S; Inoue K; Makino K; Miyashita A; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Jinnin M; Morinaga J; Ikeda T; Ihn H
    Br J Dermatol; 2019 Sep; 181(3):505-511. PubMed ID: 30706452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.
    Chen E; Cario CL; Leong L; Lopez K; Márquez CP; Chu C; Li PS; Oropeza E; Tenggara I; Cowan J; Simko JP; Chan JM; Friedlander T; Wyatt AW; Aggarwal R; Paris PL; Carroll PR; Feng F; Witte JS
    Sci Rep; 2021 Mar; 11(1):5040. PubMed ID: 33658587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
    Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
    J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PUM1 and RNase P genes as potential cell-free DNA markers in breast cancer.
    Murillo Carrasco A; Acosta O; Ponce J; Cotrina J; Aguilar A; Araujo J; Rebaza P; Pinto JA; Fujita R; Buleje J
    J Clin Lab Anal; 2021 Apr; 35(4):e23720. PubMed ID: 33522650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study.
    Rapado-González Ó; López-Cedrún JL; Lago-Lestón RM; Abalo A; Rubin-Roger G; Salgado-Barreira Á; López-López R; Muinelo-Romay L; Suárez-Cunqueiro MM
    J Oral Pathol Med; 2022 May; 51(5):429-435. PubMed ID: 35416334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.